JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

Search

Zimmer Biomet Holdings Inc

Closed

SectorHealthcare

91.34 -1.13

Overview

Share price change

24h

Current

Min

89.6

Max

91.95

Key metrics

By Trading Economics

Income

-92M

139M

Sales

242M

2.2B

P/E

Sector Avg

26.896

60.328

EPS

2.42

Dividend yield

1.01

Profit margin

6.213

Employees

17,000

EBITDA

-184M

454M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+7.01% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.01%

2.24%

Next Earnings

28 kwi 2026

Next Dividend date

30 kwi 2026

Next Ex Dividend date

25 cze 2026

Market Stats

By TradingEconomics

Market Cap

898M

19B

Previous open

92.47

Previous close

91.34

News Sentiment

By Acuity

31%

69%

112 / 348 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Zimmer Biomet Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

5 lis 2025, 19:38 UTC

Earnings

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5 lis 2025, 17:00 UTC

Earnings

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

Peer Comparison

Price change

Zimmer Biomet Holdings Inc Forecast

Price Target

By TipRanks

7.01% upside

12 Months Forecast

Average 98.92 USD  7.01%

High 110 USD

Low 88 USD

Based on 16 Wall Street analysts offering 12 month price targets forZimmer Biomet Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

16 ratings

3

Buy

10

Hold

3

Sell

Technical Score

By Trading Central

92.27 / 100.88Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Strong Bearish Evidence

Sentiment

By Acuity

112 / 348 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.
help-icon Live chat